NHS boards across the UK are using a revolutionary technology to give GPs access to rapid advice from consultant dermatologists.
CD70 CAR-T by UTC Therapeutics for Marginal Zone B-cell Lymphoma: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes